These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8058603)

  • 21. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
    Laube BL; Auci RM; Shields DE; Christiansen DH; Lucas MK; Fuchs HJ; Rosenstein BJ
    Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers.
    Coates AL; MacNeish CF; Lands LC; Meisner D; Kelemen S; Vadas EB
    Chest; 1998 Apr; 113(4):951-6. PubMed ID: 9554630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dead volume on the efficiency and the cost to deliver medications in cystic fibrosis with four disposable nebulizers.
    Ho SL; Coates AL
    Can Respir J; 1999; 6(3):253-60. PubMed ID: 10393287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis.
    Suri R
    BioDrugs; 2005; 19(3):135-44. PubMed ID: 15984899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers.
    McCallion ON; Taylor KM; Thomas M; Taylor AJ
    Pharm Res; 1995 Nov; 12(11):1682-8. PubMed ID: 8592670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
    Shak S
    Chest; 1995 Feb; 107(2 Suppl):65S-70S. PubMed ID: 7842816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RhDNase before airway clearance therapy improves airway patency in children with CF.
    van der Giessen LJ; de Jongste JC; Gosselink R; Hop WC; Tiddens HA
    Pediatr Pulmonol; 2007 Jul; 42(7):624-30. PubMed ID: 17534979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
    Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
    Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns.
    Berg EB; Picard RJ
    Respir Care; 2009 Dec; 54(12):1671-8. PubMed ID: 19961633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
    van der Giessen LJ; Gosselink R; Hop WC; Tiddens HA
    Eur Respir J; 2007 Oct; 30(4):763-8. PubMed ID: 17596273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.
    Ramsey BW; Astley SJ; Aitken ML; Burke W; Colin AA; Dorkin HL; Eisenberg JD; Gibson RL; Harwood IR; Schidlow DV
    Am Rev Respir Dis; 1993 Jul; 148(1):145-51. PubMed ID: 8317790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design principles of liquid nebulization devices currently in use.
    Rau JL
    Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of heparin aerosols generated in jet and ultrasonic nebulizers.
    Bendstrup KE; Newhouse MT; Pedersen OF; Jensen JI
    J Aerosol Med; 1999; 12(1):17-25. PubMed ID: 10351126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Particle-size distribution of bitolterol mesylate solution delivered by four compressed-air nebulizer devices.
    Hunke WA; Yu AB
    Am J Hosp Pharm; 1987 Jun; 44(6):1392-6. PubMed ID: 3618619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand.
    Hess D; Fisher D; Williams P; Pooler S; Kacmarek RM
    Chest; 1996 Aug; 110(2):498-505. PubMed ID: 8697857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers.
    Steckel H; Eskandar F
    Eur J Pharm Sci; 2003 Aug; 19(5):443-55. PubMed ID: 12907295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The choice of compressor effects the aerosol parameters and the delivery of tobramycin from a single model nebulizer.
    Standaert TA; Vandevanter D; Ramsey BW; Vasiljev M; Nardella P; Gmur D; Bredl C; Murphy A; Montgomery AB
    J Aerosol Med; 2000; 13(2):147-53. PubMed ID: 11010595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respirable mass: vague and indefinable in disease.
    Smaldone GC; Diot P; Groth M; Ilowite J
    J Aerosol Med; 1998; 11 Suppl 1():S105-11. PubMed ID: 10180720
    [No Abstract]   [Full Text] [Related]  

  • 40. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
    Sidler-Moix AL; Dolci U; Berger-Gryllaki M; Pannatier A; Cotting J; Di Paolo ER
    Pediatr Crit Care Med; 2013 Feb; 14(2):e98-102. PubMed ID: 23287904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.